372 related articles for article (PubMed ID: 33333013)
1. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.
Babiker A; Li X; Lai YL; Strich JR; Warner S; Sarzynski S; Dekker JP; Danner RL; Kadri SS
Lancet Infect Dis; 2021 May; 21(5):697-710. PubMed ID: 33333013
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
Carapetis JR; Jacoby P; Carville K; Ang SJ; Curtis N; Andrews R
Clin Infect Dis; 2014 Aug; 59(3):358-65. PubMed ID: 24785239
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
Zimbelman J; Palmer A; Todd J
Pediatr Infect Dis J; 1999 Dec; 18(12):1096-100. PubMed ID: 10608632
[TBL] [Abstract][Full Text] [Related]
4. Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016.
Couture-Cossette A; Carignan A; Mercier A; Desruisseaux C; Valiquette L; Pépin J
PLoS One; 2018; 13(10):e0206289. PubMed ID: 30352091
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children].
Fan J; Dong L; Chen Z; Bei D
Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):46-50. PubMed ID: 24680408
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections.
Zhang H; Cai Y
Lancet Infect Dis; 2021 Jun; 21(6):762. PubMed ID: 34051183
[No Abstract] [Full Text] [Related]
7. Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections - Authors' reply.
Babiker A; Dekker JP; Danner RL; Kadri SS
Lancet Infect Dis; 2021 Jun; 21(6):762-763. PubMed ID: 34051182
[No Abstract] [Full Text] [Related]
8. Invasive group A streptococcal infections in children and adolescents in Denmark during 2022-23 compared with 2016-17 to 2021-22: a nationwide, multicentre, population-based cohort study.
Nygaard U; Hartling UB; Munkstrup C; Nielsen AB; Dungu KHS; Schmidt LS; Glenthøj J; Matthesen AT; Rytter MJH; Holm M
Lancet Child Adolesc Health; 2024 Feb; 8(2):112-121. PubMed ID: 38103567
[TBL] [Abstract][Full Text] [Related]
9. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
Vilhonen J; Vuopio J; Vahlberg T; Gröndahl-Yli-Hannuksela K; Rantakokko-Jalava K; Oksi J
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1339-1348. PubMed ID: 32096108
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Antibiotic Nonsusceptibility Among Invasive Group A Streptococcus Infections-United States, 2006-2017.
Fay K; Onukwube J; Chochua S; Schaffner W; Cieslak P; Lynfield R; Muse A; Smelser C; Harrison LH; Farley M; Petit S; Alden N; Apostal M; Snippes Vagnone P; Nanduri S; Beall B; Van Beneden CA
Clin Infect Dis; 2021 Dec; 73(11):1957-1964. PubMed ID: 34170310
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of clinical manifestations and treatment strategies for invasive beta-haemolytic streptococcal infections in a Swiss tertiary hospital.
Neff A; Chok L; von Both U; Matt U; Tarnutzer A; Andreoni F; van der Linden M; Plock JA; Bühler PK; Brugger SD; Schüpbach RA; Zbinden R; Zinkernagel AS
Swiss Med Wkly; 2020 Nov; 150():w20378. PubMed ID: 33277914
[TBL] [Abstract][Full Text] [Related]
12. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
Cortés-Penfield N; Ryder JH
Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
[TBL] [Abstract][Full Text] [Related]
13. Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C/G infections.
Paspaliari DK; Sarvikivi E; Ollgren J; Vuopio J
Euro Surveill; 2023 Aug; 28(31):. PubMed ID: 37535473
[TBL] [Abstract][Full Text] [Related]
14. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study.
Hamada S; Nakajima M; Kaszynski RH; Otaka S; Goto H; Matsui H; Fushimi K; Yamaguchi Y; Yasunaga H
Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):263-270. PubMed ID: 34755257
[TBL] [Abstract][Full Text] [Related]
15. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of erythromycin-resistant emm92-type invasive group A streptococcal infections among injection drug users in West Virginia, United States, 2021-23.
Powell LM; Choi SJ; Haught BL; Demkowicz R; LaSala PR; Lukomski S
J Antimicrob Chemother; 2023 Oct; 78(10):2554-2558. PubMed ID: 37638394
[TBL] [Abstract][Full Text] [Related]
17. Invasive group A streptococcal infections requiring admission to ICU: a nationwide, multicenter, retrospective study (ISTRE study).
Orieux A; Prevel R; Dumery M; Lascarrou JB; Zucman N; Reizine F; Fillatre P; Detollenaere C; Darreau C; Antier N; Saint-Léger M; Schnell G; La Combe B; Guesdon C; Bruna F; Guillon A; Varillon C; Lesieur O; Grand H; Bertrand B; Siami S; Oudeville P; Besnard C; Persichini R; Bauduin P; Thyrault M; Evrard M; Schnell D; Auchabie J; Auvet A; Rigaud JP; Beuret P; Leclerc M; Berger A; Ben Hadj Salem O; Lorber J; Stoclin A; Guisset O; Bientz L; Khan P; Guillotin V; Lacherade JC; Boyer A; ; Orieux A; Prevel R; Dumery M; Lascarrou JB; Zucman N; Reizine F; Fillatre P; Detollenaere C; Darreau C; Antier N; Saint-Léger M; Schnell G; La Combe B; Guesdon C; Bruna F; Guillon A; Varillon C; Lesieur O; Grand H; Bertrand B; Siami S; Oudeville P; Besnard C; Persichini R; Bauduin P; Thyrault M; Evrard M; Schnell D; Auchabie J; Auvet A; Rigaud JP; Beuret P; Leclerc M; Berger A; Ben Hadj Salem O; Lorber J; Stoclin A; Guisset O; Bientz L; Khan P; Guillotin V; Lacherade JC; Boyer A
Crit Care; 2024 Jan; 28(1):4. PubMed ID: 38167516
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
19. Group A Streptococcal Infections in Children.
Ahmed MI; Saunders RV; Bandi S
Curr Pediatr Rev; 2021; 17(1):70-73. PubMed ID: 32621721
[TBL] [Abstract][Full Text] [Related]
20. Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.
Strich JR; Warner S; Lai YL; Demirkale CY; Powers JH; Danner RL; Kadri SS
Lancet Infect Dis; 2020 Oct; 20(10):1172-1181. PubMed ID: 32505231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
